HCL Tech signs multi year deal with Purdue Pharma

By : |December 2, 2010 0

NOIDA, INDIA: HCL Technologies has signed a multi year end-to-end IT Infrastructure Management engagement with pharmaceutical company Purdue Pharma L.P. The scope of this engagement covers management of two data centers and all remote locations of the client in the U.S.

HCL will also be implementing its shared Remedy V6 ITSM ticketing platform that is based on the MTaaS reference architecture and they  also responsible for implementing processes as per ITIL V3 and MTaaS platform.

Larry Pickett, chief information officer, Purdue Pharma L.P said, “We were looking at successful transition from our staff augmentation model to a IT management services model to ensure a scalable IT environment while improving our internal processes. We look forward to leveraging HCL’s  tools, processes and IT management practices to reach our business objectives. ”

                                 

___________________________________________________________________________________________________________

Anant Gupta, president, HCL Technologies Infrastructure Services Division, said “HCL’s engagement with Purdue Pharma is another feather in the cap for HCL Technologies in the Life Sciences Industry. We are committed towards operational transformation for Purdue Pharma by moving its IT infrastructure to a proactive IT management services model and look forward to a long and mutually rewarding partnership.”

HCL Technologies will also installing MyDashboard, the real time reporting tool for the complete visibility of different layers of the IT infrastructure for management reporting at Purdue Pharma.

HCL has also been positioned in the Magic Quadrants for Desktop and Helpdesk Outsourcing in Europe.

The company has had announced many global engagements like Singapore Stock Exchange, Al- Majdouie group, Electrolux, Nokia, Reader’s Digest Association, Dr. Pepper Snapple Group, Energy Future Holdings and Viacom Inc.

No Comments so fars

Jump into a conversation

No Comments Yet!

You can be the one to start a conversation.